Contemporary Assessment of Adhesiolysis and Resection for Adhesive Small Bowel Obstruction in the State of New York
Surgical Innovation · 2024
DOI: 10.1177/15533506241240580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Innovation, 2024. Verfasst von Matthew M Symer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Colon and Rectal Surgery, NYU Long Island School of Medicine, Mineola, NY, USA. Hauptthemen laut MEDLINE: Intestinal Obstruction, Intestine, Small. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Adhesive small bowel obstruction (aSBO) is a common surgical problem, with some advocating for a more aggressive operative approach to avoid recurrence. Contemporary outcomes in a real-world setting were examined. Study Design A retrospective cohort study was performed using the New York Statewide Planning and Research Cooperative database to identify adults admitted with aSBO, 2016-2020. Patients were stratified by the presence of inflammatory bowel disease (IBD) and cancer history. Diagnoses usually requiring resection were excluded. Patients were categorized into four groups: non-operative, adhesiolysis, resection, and ‘other’ procedures. In-hospital mortality, major complications, and odds of undergoing resection were compared.
Results
58,976 patients were included. 50,000 (84.8%) underwent non-operative management. Adhesiolysis was the most common procedure performed (n = 4,990, 8.46%), followed by resection (n = 3,078, 5.22%). In-hospital mortality in the lysis and resection groups was 2.2% and 5.9% respectively. Non-IBD patients undergoing operation on the day of admission required intestinal resection 29.9% of the time. Adjusted odds of resection were highest for those with a prior aSBO episode (OR 1.29 95%CI 1.11-1.49), delay to operation ≥3 days (OR1.78 95%CI 1.58-1.99), and non-New York City (NYC) residents being treated at NYC hospitals (OR1.57 95%CI 1.19-2.07).
Conclusion
Adhesiolysis is currently the most common surgery for aSBO, however nearly one-third of patients will undergo a more extensive procedure, with an increased risk of mortality. Innovative therapies are needed to reduce the risk of resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Colon and Rectal Surgery, NYU Long Island School of Medicine, Mineola, NY, USA.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
- Department of Radiology, Division of Vascular and Interventional Radiology, Weill Cornell Medicine, New York, NY, USA.
- Department of Surgery, Division of Colon and Rectal Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, NY, USA.
ORCID-Profile: Matthew M Symer
Zitieren
APA
Symer, M. M., Zheng, X., Pua, B. B., Sedrakyan, A., & Milsom, J. W. (2024). Contemporary Assessment of Adhesiolysis and Resection for Adhesive Small Bowel Obstruction in the State of New York. Surgical Innovation. https://doi.org/10.1177/15533506241240580
Vancouver
Symer MM, Zheng X, Pua BB, Sedrakyan A, Milsom JW. Contemporary Assessment of Adhesiolysis and Resection for Adhesive Small Bowel Obstruction in the State of New York. Surgical Innovation. 2024. doi:10.1177/15533506241240580
BibTeX
@article{Symer2024,
author = {Symer, Matthew M and Zheng, Xinyan and Pua, Bradley B and Sedrakyan, Art and Milsom, Jeffrey W},
title = {Contemporary Assessment of Adhesiolysis and Resection for Adhesive Small Bowel Obstruction in the State of New York},
journal = {Surgical Innovation},
year = {2024},
doi = {10.1177/15533506241240580}
}
EUVIMED